New York City has issued 16 office-conversion permits since July’s Pfizer building scare, according to CRE Daily’s October 27 brief. The brief describes a rebound while higher rates and a firmer office market slow the pace.
The distinction is between regulatory progress and delivered housing. Sixteen permits are not sixteen completed buildings, and the summary does not establish a delivery schedule or investment return.
Our read: a conversion underwriting should separately test structural diligence, approvals, financing and the alternative value of continuing office use. A citywide permit count cannot substitute for project-level feasibility. Detailed construction and financing claims from the imported research are omitted here because the accessible source summary does not independently establish them.
Key Takeaways
- Conversion permitting has resumed, but delivery and returns still depend on project execution.
- The publicly accessible source summary supports the permit count and broad constraints, not the imported project-specific cost and timing claims.
CRE Daily — NYC Office Conversions Rebound After Pfizer Building Scare, October 27, 2026 · https://www.credaily.com/briefs/nyc-office-conversions-rebound-after-pfizer-building-scare/ · Verified publiclyaccessible October27 summary: NYCissued16conversionpermitssinceJulyPfizerbuildingscare;higherratesandfirmerofficemarket slowdownpace. Permitsnotcompletedunits. Allunverifiedproject-specificloans,timelines,rentsandcostsremoved. Our read is analysis.
Never miss a Signal
Get the daily brief that busy CRE professionals rely on.